A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clon
A 12-Month Open-Label Study to Evaluate the Safety and Tolerability of Pregabalin as Adjunctive Therapy in Pediatric Subjects 1 Month to 16 Years of Age With Partial Onset Seizures and Pediatric and Adult Subjects 5 to 65 Years of Age With Primary Generalized Tonic-Clonic Seizures
Category & Conditions: Neurological Diseases and Conditions
Medicine: LYRICA® AND LYRICA®CR(PREGABALIN) AND (PREGABALIN EXTENDED RELEASE TABLETS)
ClinicalTrials.gov Identifier (NCT): NCT01463306
Protocol ID: A0081106
PrintDownloadOpen Plain Language Summary Result: Click here